Search
Search Results
-
Hepatitis B Virus Methods and Protocols
This detailed new edition collects state-of-the-art methods in the fields of hepatitis B virus (HBV) molecular biology and immunology. The book...
-
Hepatitis Viruses: Hepatitis B and Hepatitis D
Infection with hepatitis B virus (HBV) is the most common cause of chronic hepatitis and hepatocellular carcinoma in the world today despite the...
-
Hepatitis B virus reactivation in seronegative occult hepatitis B patient receiving ibrutinib therapy
BackgroundIbrutinib is a Bruton’s tyrosine kinase (BTK) inhibitor approved for the treatment for several mature B-cell malignancies. Reactivation of...
-
Spontaneous reactivation of hepatitis B virus with multiple novel mutations in an elderly patient with resolved hepatitis B virus infection
Spontaneous reactivation of the Hepatitis B virus (HBV) is rare in individuals with previously resolved infections. This report presents the case of...
-
Path to Cure Hepatitis B: How Far Are We?
Hepatitis B infection is caused by the hepatitis B virus (HBV), which damages the liver and can lead to chronic liver diseases such as cirrhosis and...
-
Chronic Hepatitis B
Hepatitis B is a DNA virus (HBV) that causes an acute and chronic infection. The HBV is transmitted vertically from mother to child, from child to...
-
Characteristics and clinical treatment outcomes of chronic hepatitis B children with coexistence of hepatitis B surface antigen (HBsAg) and antibodies to HBsAg
BackgroundThe coexistence of hepatitis B surface antigen (HBsAg) and hepatitis B surface antibody (HBsAb) represents an uncommon serological pattern...
-
Hepatitis B discrimination: global responses requiring global data
Over 250 million individuals live with chronic hepatitis B (CHB) infection worldwide. A significant proportion of these people often face...
-
Outcomes of Entecavir Prophylaxis in Hepatitis B Immune Patients Receiving Hepatitis B Infected Kidneys: A Single Center Experience
Purpose of ReviewHepatitis B (HBV) vaccinated patients have mixed responses with regard to antibody titers and subsequent level of immunity. This...
-
High Rates of Seroprotection to Hepatitis B After a Hepatitis B Challenge Dose in Previously Vaccinated Patients with Inflammatory Bowel Disease on Immunosuppressive Therapy
BackgroundHealthy populations have high rates of sustained vaccine-induced seroprotection to hepatitis B virus, but previous studies in...
-
Tg1.4HBV-s-rec mice, a crossbred hepatitis B virus-transgenic model, develop mild hepatitis
Hepatitis B virus (HBV)-transgenic mice exhibit competent innate immunity and are therefore an ideal model for considering intrinsic or cell-based...
-
A conceptual model for chronic hepatitis B and content validity of the Hepatitis B Quality of Life (HBQOL) instrument
BackgroundThere is increased emphasis on incorporating patient perspectives and patient-relevant endpoints in drug development. We developed a...
-
Using Intelligent System for Diagnosis of Chronic Hepatitis B
Artificial Intelligence can be defined as a computer’s coordination of planning, or a computer program that evaluates systematically, fairly, and...
-
Chronic Hepatitis B
Hepatitis B virus (HBV) is a stealth virus that is transmitted by percutaneous route and leads to chronic hepatitis B (CHB) infection if exposed...
-
Comparison of inpatient outcomes in patients with Hepatitis B, Hepatitis C, and Hepatitis B and C co-infection with Cirrhosis
BackgroundHepatitis B (HBV) and Hepatitis C (HCV) are among the most common causes of cirrhosis in the USA, with high mortality and morbidity but...
-
Host sex disparity and viral genotype dependence of the glycosylation level of small Hepatitis B surface protein in patients with HBeAg-positive chronic Hepatitis B
BackgroundHepatitis B surface antigen (HBsAg) consists of six components of large/middle/small HBs proteins (L/M/SHBs) with non-glycosylated (ng)- or...
-
Hepatitis B Virus Elimination Strategies
Purpose of ReviewThe World Health Assembly called to eliminate viral hepatitis as a public health threat in 2016 and proposed elimination goals by...
-
Survey of lived experiences and challenges in hepatitis B management and treatment
Almost 300 million people are living with chronic hepatitis B infection worldwide and most remain undiagnosed and at risk for liver cancer. In 2015...
-
Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan
BackgroundHepatitis B virus (HBV) is one of the most prevalent chronic viral infections that causes chronic hepatitis B (CHB). In Japan, genotypes B...
-
Reverse Vaccinology and Immunoinformatic Approach for Designing a Bivalent Vaccine Candidate Against Hepatitis A and Hepatitis B Viruses
Hepatitis A and B are two crucial viral infections that still dramatically affect public health worldwide. Hepatitis A Virus (HAV) is the main cause...
